Researchers at Ben-Gurion University have identified how the GLP-1 receptor agonist semaglutide and the anti-inflammatory medication colchicine act on the heart to prevent the development of Atrial Fibrillation. It can offer new ways to treat patients before AF takes hold.
https://www.bgu.ac.il/en/news-and-articles/bgu-study-maps-drugs-against-af/
https://academic.oup.com/europace/article/28/5/euag091/8660492?login=false